National Eldercare Referral System, Inc. – Trademark Portfolio

Entity Type: 03

National Eldercare Referral System, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include FIELDSCOUT and CARESCOUT RATINGS. The owner is based in Wellesley, MA.

36 Washington Street Suite 250

Wellesley, MA 02481

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

National Eldercare Referral System, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does National Eldercare Referral System, Inc. have?

National Eldercare Referral System, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.

What trademark classes does National Eldercare Referral System, Inc. file in?

National Eldercare Referral System, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.

What are National Eldercare Referral System, Inc.'s most well-known trademarks?

National Eldercare Referral System, Inc.'s registered trademark portfolio includes well-known marks such as FIELDSCOUT and CARESCOUT RATINGS. These are among 2 currently registered trademarks in the portfolio.

What is National Eldercare Referral System, Inc.'s trademark registration success rate?

National Eldercare Referral System, Inc. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.